Literature DB >> 18584332

Lipopolysaccharide-induced pro-inflammatory cytokines in the brain of rats in the morphine-tolerant state.

Linda Staikos1, Lorenc Malellari, Sulie L Chang.   

Abstract

Lipopolysaccharide (LPS) induces the production of inflammatory cytokines in the serum and brain; morphine has been shown to be immunosuppressive. However, we previously reported that serum levels of LPS-induced tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and interleukin-6 (IL-6) are potentiated during morphine tolerance due to the HPA axis desensitization. In this study, we examined LPS-induced cytokine production in the brain of morphine-tolerant rats. The animals were implanted with two and four morphine (75 mg) pellets on days 1 and 2, respectively. On either day 4 or 5, 250 microg/kg LPS was administered (i.p.). Animals implanted with placebo and injected with saline were used as the control. The animals were sacrificed either 16 or 2 h post-injection, respectively, and TNF-alpha, IL-1beta, and IL-6 mRNA levels in the brain were determined by reverse transcriptase polymerase chain reaction. IL-1beta mRNA increased 2 h post-LPS treatment, whereas IL-6 decreased. At 16 h, TNF-alpha expression mRNA increased. These data suggest that the inflammatory response in the brain is heightened during morphine tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584332     DOI: 10.1007/s11481-008-9111-9

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  15 in total

Review 1.  Proinflammatory cytokines.

Authors:  C A Dinarello
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

2.  Real-time PCR assay targets the 23S-5S spacer for direct detection and differentiation of Legionella spp. and Legionella pneumophila.

Authors:  Bjorn L Herpers; Bartelt M de Jongh; Kim van der Zwaluw; Erik J van Hannen
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 3.  Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.

Authors:  Mary Jeanne Kreek; David A Nielsen; Eduardo R Butelman; K Steven LaForge
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

4.  Differential expression of cytokines in the brain and serum during endotoxin tolerance.

Authors:  Ru Chen; Heping Zhou; Jose Beltran; Lorenc Malellari; Sulie L Chang
Journal:  J Neuroimmunol       Date:  2005-06       Impact factor: 3.478

Review 5.  Effects of opioid tolerance and withdrawal on the immune system.

Authors:  Toby K Eisenstein; Rahil T Rahim; Pu Feng; Nita K Thingalaya; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

Review 6.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

7.  Chronic morphine potentiates the inflammatory response by disrupting interleukin-1beta modulation of the hypothalamic-pituitary-adrenal axis.

Authors:  S D House; X Mao; G Wu; D Espinelli; W X Li; S L Chang
Journal:  J Neuroimmunol       Date:  2001-08-30       Impact factor: 3.478

8.  Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia.

Authors:  H Saito; C Patterson; Z Hu; M S Runge; U Tipnis; M Sinha; J Papaconstantinou
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

Review 9.  The effects of interaction between morphine and interleukin-1 on the immune response.

Authors:  S L Chang; G D Wu; N A Patel; E L Vidal; M Fiala
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

10.  Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision.

Authors:  DeYong Liang; Xiaoyou Shi; Yanli Qiao; Martin S Angst; David C Yeomans; J David Clark
Journal:  Mol Pain       Date:  2008-02-22       Impact factor: 3.395

View more
  3 in total

1.  CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.

Authors:  Chiung-Yuan Ko; Ling-Hua Chang; Yi-Chao Lee; Esta Sterneck; Chun-Pei Cheng; Shun-Hua Chen; A-Mei Huang; Joseph T Tseng; Ju-Ming Wang
Journal:  Neurobiol Aging       Date:  2010-11-26       Impact factor: 4.673

Review 2.  The HIV-1 transgenic rat model of neuroHIV.

Authors:  Michael Vigorito; Kaitlyn P Connaghan; Sulie L Chang
Journal:  Brain Behav Immun       Date:  2015-02-27       Impact factor: 7.217

3.  Interleukin-1 beta-induced up-regulation of opioid receptors in the untreated and morphine-desensitized U87 MG human astrocytoma cells.

Authors:  Linda Staikos Byrne; Jinsong Peng; Sraboni Sarkar; Sulie L Chang
Journal:  J Neuroinflammation       Date:  2012-11-20       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.